APLS  220121C00045000

Sold all APLS $45 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Jay singh

Bought APLS $45 Calls

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such a

Apellis Pharmaceuticals, Inc. Common Stock

Bought to close all APLS

Taylor Duran

Sold short APLS

Sold all APLS

Felix Liu

New position in APLS

Vincent

James Li